Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2023/05/052663
CTRI/2023/05/052663Not yet recruitingNot Applicable

Comparative clinical study in the management of Prasramsini Yoni Vyapad w.s.r to utero-vaginal prolapse with Kapikachhu Mula Kwatha and Laghu Phala Ghrita

Dr Swagatika Padhan1 site in 1 country60 target enrollmentStarted: May 24, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
To manage the degree of prolapse in Prasramsini Yonivyapad
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

It is expected that the present clinical study will bring out a standard and effective treatment in the management of prasramsini yonivyapad w.s.r. to uterovaginal prolapse.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Not Applicable

Eligibility Criteria

Ages
20.00 Year(s) to 65.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • •Married women First and second degree uterovaginal prolapse.

Exclusion Criteria

  • •Unmarried women Complete uterovaginal prolapse Congenital abnormalities of genital tract Benign and malignant growthin genital tract History of pelvic and vaginal surgery Pregnancy PID.

Outcomes

Primary Outcomes

To manage the degree of prolapse in Prasramsini Yonivyapad

Time Frame: 3 months

Secondary Outcomes

  • To control the symptoms(1 month, 2 months, 3 months)

Investigators

Sponsor
Dr Swagatika Padhan
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
Assessing Best Medical Treatment Patterns of Patients With Symptomatic Peripheral Arterial Occlusive Disease in GermanyPeripheral Artery DiseaseCritical Limb IschemiaIntermittent Claudication
NCT03909022Universitätsklinikum Hamburg-Eppendorf60,000
Unknown
Phase 2
The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in ChildrenHenoch-Schoenlein Purpura Nephritis
NCT02532790Nanjing Children's Hospital100
Unknown
Phase 2
The Research of Standard Diagnosis and Treatment for HSPN in ChildrenHenoch-Schoenlein Purpura Nephritis
NCT02532777Nanjing Children's Hospital100
Unknown
Phase 2
The Research of Standard Diagnosis and Treatment for Severe HSP in ChildrenHenoch-Schoenlein Purpura
NCT02540720Nanjing Children's Hospital30
Not yet recruiting
Phase 3
Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic SteatohepatitisNonalcoholic Steatohepatitis
NCT05731596Tanta University46